Wedge Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-9,533	Closed	-$786K	–	567
2016 Q2	$786K	Sell	9,533 -1,623	-15%	-$134K	0.01%	354
2016 Q1	$847K	Sell	11,156 -19	-0.2%	-$1.41K	0.01%	338
2015 Q4	$898K	Buy	11,175 +900	+9%	+$64.9K	0.01%	341
2015 Q3	$653K	Buy	10,275 +1,550	+18%	+$111K	0.01%	395
2015 Q2	$614K	Buy	8,725 +2,125	+32%	+$157K	0.01%	418
2015 Q1	$523K	Buy	6,600 +100	+2%	+$7.38K	0.01%	440
2014 Q4	$414K	Sell	6,500 -900	-12%	-$56.4K	﹤0.01%	467
2014 Q3	$442K	Buy	7,400 +875	+13%	+$50.1K	﹤0.01%	460
2014 Q2	$349K	Buy	6,525 +3,000	+85%	+$165K	﹤0.01%	479
2014 Q1	$213K	Buy	+3,525	New	+$205K	﹤0.01%	483
2013 Q4	–	Sell	-5,000	Closed	-$231K	–	497
2013 Q3	$231K	Sell	5,000 -800	-14%	-$36.7K	﹤0.01%	452
2013 Q2	$238K	Buy	+5,800	New	+$248K	﹤0.01%	450